0001140361-11-029071.txt : 20110520
0001140361-11-029071.hdr.sgml : 20110520
20110520161112
ACCESSION NUMBER: 0001140361-11-029071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110518
FILED AS OF DATE: 20110520
DATE AS OF CHANGE: 20110520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SABEL IVAN R
CENTRAL INDEX KEY: 0001217563
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 11861742
MAIL ADDRESS:
STREET 1: TWO BETHESDA METRO CENTER SUITE 1200
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0303
4
2011-05-18
0
0000722723
HANGER ORTHOPEDIC GROUP INC
HGR
0001217563
SABEL IVAN R
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
1
0
0
0
Common Stock
2011-05-18
4
A
0
6500
0
A
169194
D
Common Stock
2011-05-18
4
A
0
1283
25.72
A
170477
D
Common Stock
1100
I
IRA
Common Stock
1100
I
Spouse's IRA
Option to Buy
14.23
2003-05-30
2012-05-29
Common Stock
100000
100000
D
Option to Buy
13.80
2004-08-01
2013-07-31
Common Stock
90000
90000
D
Consists of restricted stock units granted under the Company's 2010 Omnibus Incentive Plan (the "Plan"), which vest to the extent of one-third on May 18, 2012 and cumulatively vest to the extent of one-third each year thereafter, subject to certain provisions of the Plan.
Consists of restricted stock units which the Reporting Person elected to receive in lieu of the annual director fee payable to the Reporting Person.
This option was fully vested on June 23, 2005.
/s/ Teri L. Champ, Attorney-in-Fact for Ivan R. Sabel
2011-05-20